期刊文献+

Ki-67、P—gp在局部晚期宫颈癌组织中的表达及与新辅助化疗疗效的研究 被引量:2

Expression of Ki-67 and P-gp in locally advanced cervical cancer and their correlation study with the effect of neoadjuvant chemotherapy
原文传递
导出
摘要 目的分析局部晚期宫颈癌(LACC)组织中Ki-67、P糖蛋白(P-gp)的表达与新辅助化疗(NACT)疗效的关系,探讨二者的共表达性及临床病理意义。方法运用免疫组化法对53例LACC患者进行NACT前Ki-67、P-gp的表达量进行检测。结果53例LACC患者中有效32例(60.4%)。NACT疗效与Ki-67、P—gp的表达显著相关(P=0.006、0.029),Logistic回归显示Ki-67表达量越高、P—gp表达量越低,NACT越敏感(B=2.163、-3.39)。Spearman分析显示尚不能认为Ki-67与P—gp相关(P=0.325),且尚不能认为二者的共表达性与深肌层浸润、盆腔淋巴结转移相关(P=0.242、0.871)。结论NACT可用于LACC的治疗,Ki-67、P-gp可作为预测NACT疗效的指标。 Objective To study the correlation between expression of Ki-67, P-gp and effect of neoadjuvant chemotherapy(NACT) in locally advanced cervical cancer(LACC), and to investigate coexpression of Ki-67, P-gp and its siginificance. Methods Fifty-three cases of LACC biopsy specimens before treatment were collected. Expression of Ki-67 and P-gp was analyzed with the technique of immu- nohistochemical staining. Results Thirty-two cases were effective among the total cases(60. 4% ). There was siginificant correlation of the expression of Ki-67, p-gp with the effect of NACT (P = 0. 006, 0. 029). High expression of Ki-67 and low expression of P-gp were positive factors for effect of NACT through results of the logistic regression ( β = 2. 163, - 3.39 ). The results of the spearman corelations showed that there was no correlation of the expression of Ki-67 with P-gp(p =0. 325). Co-expression of Ki-67, P-gp showed no relationship with deep stromal invasion and pelvic lymph node metastasis (p = 0. 242, 0. 871 ). Conclusions NACT can be applied to treatment of LACC, and the expression of Ki-67 and P-gp are indicators of predicting the effect of NACT.
作者 窦蒙蒙 王莉
出处 《中国实用医刊》 2015年第8期1-4,共4页 Chinese Journal of Practical Medicine
基金 河南省医学科技攻关计划项目(豫卫科[2010]17号)
关键词 局部晚期宫颈癌 新辅助化疗 KI-67 P糖蛋白 Locally advanced cervical cancer Neoadjuvant chemotherapy Ki-67 P-gp
  • 相关文献

参考文献19

  • 1Katsumata N. Reply: Comment on Phase Ⅲ randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical sur- gery alone for stages IB2, llA2, and ⅡB cervical cancer: a Japan Clinical OncologbT Group trial ( JCOG 0102) [ J]. Br J Cancer,2013, 109(9) :2506.
  • 2连丽娟.林巧稚妇科肿瘤学[M].北京:人民卫生出版社,2006:452-458.
  • 3王光,黄玲惠,魏丽惠,王悦,李小平,王建六,王世军,沈丹华,张博雅.宫颈癌新辅助化疗疗效分析[J].中国妇产科临床杂志,2013,14(1):20-22. 被引量:35
  • 4Wang J, Zhang J, Zhang L, et al. Expression of P-gp, MRP,LRP,GST-IIand Topollct and Acquired Resistance to Cisplatin in Human Lung Adenocarcinoma Cells [ J]. Oncol Rep, 2011,26 (5) :1081-1089.
  • 5Lu LI, Katsaros D, Wiley A, et al. Expression of MDR1 in epithelial ovarian cancer and its association with disease progression[J]. Oncol Res, 2007, 16(8) :395-403.
  • 6Li XR, Liu M, Zhang YJ,et al. Evaluation of ER, PgR, HER-2, Ki- 67, cyclin D1, and nm23-Hl protein expression as predictors of patho- logical complete response to neoadjuvant chemotherapy for locally ad- vanced breast cancer [J]. Med Oncol,2011,28(1 Suppl) :48-54.
  • 7Yan H, Wang R, Yu J,et al. Predictive value of Smac, VEGF and Ki-67 in rectal cancer treated with neoadjuvant therapy [ J ]. Oncol Lett,2010,1 (4) : 641-647.
  • 8Freudlsperger C, Freier K, Hoffmann J, et al. Ki-67 expression pre- dicts radiosensitivity in oral squamous cell carcinoma [ J]. Int J Oral Maxillofac Surg,2012,41 ( 8 ) : 965-969.
  • 9Martin P, Nicolaus F, Christian R, et al. Changes in Ki-67 labeling indices during neoadjuvant chemotherapy for advanced ovarian cancer are associated with survival[J]. Int J Gynecol Cancer,2010,20(4) : 555-560.
  • 10Yin M, Zhang H, Li H, et al. The toxicity and long term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer [J ]. Journal of Surgical Oncology, 2012,105(2) :206-211.

二级参考文献34

  • 1王莉,刘风花,刘若男.宫颈鳞癌新辅助化疗敏感性预测指标研究[J].医药论坛杂志,2004,25(20):15-16. 被引量:5
  • 2程晓东,吕卫国,叶枫,陈怀增,谢幸.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006,41(2):95-98. 被引量:66
  • 3张凡,常永霞,张九鸿,成日青,赵秀芳.早期宫颈癌耐药基因与临床预后关系回顾性研究[J].河北北方学院学报(医学版),2006,23(1):1-7. 被引量:2
  • 4高国兰,万红英,邹学森,陈文学,陈岳青,黄秀珍.子宫颈癌组织三磷酸腺苷肿瘤体外药物敏感试验及其与耐药蛋白表达的关系[J].中华妇产科杂志,2007,42(3):201-205. 被引量:9
  • 5Tierney J.Neoadjuvant chemotherapy for locally advanced cervical cancena systematic review and meta-analysis of individual patient data from 21 randomised trials[J].Eur J Cancer,2003,39(17):2470-2486.
  • 6Walker J.Martin C,Callaghan R.Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restor anticancer drug efficacy[J].Euro J Cancer,2002,40(4):594-605.
  • 7Benedetti PP,Geogi S.Colombo A,et al.Neoadjuvant intraarterial chemotherapy and radical surgery versus exclusive radiotherapy in locally Advanced squamous cell cervical cancer:results from the Italian multicenter randomized study[J].Clin Oncol,2002,20:179-188.
  • 8Konishi I.Nanbu K,Mandai M,et al.Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma[J].GynecolOncol,1998,70(3):365-337.
  • 9Oguri T,Fujiwara Y,Miyazaki M,et al.Induction of gamma-glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients[J].Ann Oncol,1999,10(4):455-460.
  • 10Benlloch M,Ortega A.Ferrer P.Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastaic B16 melanoma cells to endothelium-induced cytoxicity[J].J Biol Chem,2005,280(8):6950-6959.

共引文献59

同被引文献22

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部